Wednesday, October 29, 2014
The Market for Non-Small-Cell Lung Cancer Will Grow to $8.5 Billion in 2023, Driven by the Entry of Thirteen Novel Drugs
… novel therapies into the non-small-cell lung cancer (NSCLC) market will drive the … the Pharmacor report entitled Non-Small-Cell Lung Cancer:
Sequential treatment of tyrosine kinase …
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment